Clinical and Biochemical Parameters in Relation to Serum Fetuin-A Levels in Overweight and Obese with and without Metabolic Syndrome in the North-eastern States of Indian Population.

IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL JMA journal Pub Date : 2024-10-15 Epub Date: 2024-09-13 DOI:10.31662/jmaj.2024-0104
Sruti Eswar, Balaji Rajagopalan, Kenyi Ete, Srinivasa Nageswara Rao Gattem
{"title":"Clinical and Biochemical Parameters in Relation to Serum Fetuin-A Levels in Overweight and Obese with and without Metabolic Syndrome in the North-eastern States of Indian Population.","authors":"Sruti Eswar, Balaji Rajagopalan, Kenyi Ete, Srinivasa Nageswara Rao Gattem","doi":"10.31662/jmaj.2024-0104","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong><b>:</b> In India the prevalence of metabolic syndrome has dramatically increased. Hepatokines have gained considerable interest, and the role of fetuin-A in overweight and obesity incompletely understood. Therefore, this study aimed to investigate the role of serum fetuin-A in overweight and obese adults with and without metabolic syndrome in the northeastern Indian population.</p><p><strong>Methods: </strong>This comparative study included 200 subjects (50 control, 50 overweight, 50 obese without metabolic syndrome and 50 obese with metabolic syndrome) aged 20-70 years. Lipid profile and fasting blood glucose, were measured using a fully automated analyzer. ELISA was employed to measure serum fetuin-A levels. Statistical analyses were conducted using SPSS versions 23.0. Furthermore, <i>t</i>-test was used to analyze the numerical investigational data of the present study. Chi squared test for the categorical data, and Pearson's correlation for the correlation analysis.</p><p><strong>Results: </strong>Overweight and obese adults with and without metabolic syndrome had higher fetuin-A levels were than the controls. The results of this study indicated a positive correlation between fetuin-A and lipid profile, anthropometric parameters, 12 h fasting blood glucose and blood pressure. Contrarily, HDL-C exhibited a negative correlation with fetuin-A.</p><p><strong>Conclusions: </strong>Fetuin-A is the first hepatokine associated with metabolic diseases. It controls the entire energy homeostasis of the body probably by regulating glucose and lipid metabolism. The current data belief is that fetuin-A may be a promising biomarker for predicting metabolic syndrome and its associated disorders particularly in overweight and obese adults.</p>","PeriodicalId":73550,"journal":{"name":"JMA journal","volume":"7 4","pages":"529-535"},"PeriodicalIF":1.5000,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543339/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMA journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31662/jmaj.2024-0104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: : In India the prevalence of metabolic syndrome has dramatically increased. Hepatokines have gained considerable interest, and the role of fetuin-A in overweight and obesity incompletely understood. Therefore, this study aimed to investigate the role of serum fetuin-A in overweight and obese adults with and without metabolic syndrome in the northeastern Indian population.

Methods: This comparative study included 200 subjects (50 control, 50 overweight, 50 obese without metabolic syndrome and 50 obese with metabolic syndrome) aged 20-70 years. Lipid profile and fasting blood glucose, were measured using a fully automated analyzer. ELISA was employed to measure serum fetuin-A levels. Statistical analyses were conducted using SPSS versions 23.0. Furthermore, t-test was used to analyze the numerical investigational data of the present study. Chi squared test for the categorical data, and Pearson's correlation for the correlation analysis.

Results: Overweight and obese adults with and without metabolic syndrome had higher fetuin-A levels were than the controls. The results of this study indicated a positive correlation between fetuin-A and lipid profile, anthropometric parameters, 12 h fasting blood glucose and blood pressure. Contrarily, HDL-C exhibited a negative correlation with fetuin-A.

Conclusions: Fetuin-A is the first hepatokine associated with metabolic diseases. It controls the entire energy homeostasis of the body probably by regulating glucose and lipid metabolism. The current data belief is that fetuin-A may be a promising biomarker for predicting metabolic syndrome and its associated disorders particularly in overweight and obese adults.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
印度东北部各邦有代谢综合征和无代谢综合征的超重和肥胖者血清 Fetuin-A 水平与临床和生化参数的关系。
导言:在印度,代谢综合征的发病率急剧上升。肝脏激素已引起了人们的极大兴趣,而胎儿素-A 在超重和肥胖症中的作用尚未完全明了。因此,本研究旨在调查血清胎球蛋白-A 在印度东北部人群中患有和未患有代谢综合征的超重和肥胖成年人中的作用:这项比较研究包括 200 名受试者(50 名对照组、50 名超重组、50 名无代谢综合征的肥胖组和 50 名有代谢综合征的肥胖组),年龄在 20-70 岁之间。使用全自动分析仪测量血脂和空腹血糖。采用 ELISA 方法测量血清胎脂素-A 水平。统计分析采用 SPSS 23.0 版本。此外,本研究的数字调查数据采用 t 检验。结果:结果:与对照组相比,患有或未患有代谢综合征的超重和肥胖成人的胎盘素-A水平较高。研究结果表明,胎脂素-A 与血脂概况、人体测量参数、12 小时空腹血糖和血压呈正相关。相反,高密度脂蛋白胆固醇与胎盘素-A呈负相关:Fetuin-A是第一个与代谢性疾病相关的肝脏标志物。结论:胎素 A 是第一个与代谢性疾病相关的肝脏标志物,它可能通过调节葡萄糖和脂质代谢来控制整个机体的能量平衡。目前的数据认为,胎儿素-A 可能是预测代谢综合征及其相关疾病(尤其是超重和肥胖成年人)的一种有前途的生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
High Prevalence of Nephrocalcinosis in Hypophosphatasia Patients with the ALPL c.1559del Gene Variant. Hospital-based Introduction of Untested High-risk Foods for Down Syndrome Infant with Severe Food Protein-induced Enterocolitis Syndrome: A Case Report. How Healthy Lifestyle Habits Have Interacted with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccinations: A Comment. How Will Work Hour Restrictions Transform the Working Conditions of Resident Physicians? Hypotensive Dumping Syndrome in Hypertrophic Obstructive Cardiomyopathy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1